133
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Cross-Cultural Adaptation Of The Persian Version Of Test Of The Adherence To Inhalers (TAI)

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1693-1699 | Published online: 03 Oct 2019

References

  • Lin W-C, Huang T-Y, Liu C-Y, Yeh M-L, Yu C-H, Hwang S-L. Validation of the clinical COPD questionnaire in Taiwan. Copd. 2016;13(3):360–366. doi:10.3109/15412555.2015.109445626678264
  • Blanco I, Diego I, Bueno P, et al. Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique. Int J Chron Obstruct Pulmon Dis. 2018;13:57. doi:10.2147/COPD.S15085329317811
  • Amininasab S, Lolaty H, Moosazadeh M, Shafipour V. Medication adherence and its predictors among patients with heart failure. Nursing Midwifery Stud. 2018;7(2):81–86. doi:10.4103/nms.nms_9_17
  • Sharifi H, Masjedi MR, Emami H, et al. Interim report from burden of obstructive lung disease (BOLD Study) in Tehran: prevalence and risk factors of chronic obstructive pulmonary disease. Tanaffos. 2014;13(3):6–13.
  • Pitta F, Troosters T, Probst VS, Langer D, Decramer M, Gosselink R. Are patients with COPD more active after pulmonary rehabilitation? Chest J. 2008;134(2):273–280. doi:10.1378/chest.07-2655
  • Henrich R, Logue M. Feasibility of using the test for adherence to inhalers tool and tailoring education to the individual with chronic obstructive pulmonary disease. J Nurse Pract. 2017;13(10):e481–e483. doi:10.1016/j.nurpra.2017.07.025
  • Bonini M, Usmani OS. The importance of inhaler devices in the treatment of COPD. COPD Res Pract. 2015;1(1):9. doi:10.1186/s40749-015-0011-0
  • Farahani DF, Shamsi M, Khorsandi M, Rezanfar MR, Ranjbaran M. The relationship between perceived barriers and non-medication adherence in type 2 diabetic patients in Arak in 2014. Daneshvar Med. 2015;22:49–58.
  • Krska J, Katusiime B, Corlett SA. Validation of an instrument to measure patients’ experiences of medicine use: the living with medicines questionnaire. Patient Prefer Adherence. 2017;11:671. doi:10.2147/PPA.S13479228405159
  • Simoni-Wastila L, Wei Y-J, Qian J, et al. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population. Am J Geriatr Pharmacother. 2012;10(3):201–210. doi:10.1016/j.amjopharm.2012.04.00222521808
  • Olszanecka-Glinianowicz M, Almgren-Rachtan A. The adherence and illness perception of patients diagnosed with asthma or chronic obstructive pulmonary disease treated with polytherapy using new generation Cyclohaler. Postepy Dermatologii I Alergologii. 2014;31(4):235–246. doi:10.5114/pdia.2014.4507025254009
  • Lacasse Y, Archibald H, Ernst P, Boulet LP. Patterns and determinants of compliance with inhaled steroids in adults with asthma. Can Respir J. 2005;12(4):211–217. doi:10.1155/2005/37545416003458
  • Krigsman K, Moen J, Nilsson JL, Ring L. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period. J Clin Pharm Ther. 2007;32(6):603–611. doi:10.1111/j.1365-2710.2007.00866.x18021338
  • Neugaard BI, Priest JL, Burch SP, Cantrell CR, Foulis PR. Quality of care for veterans with chronic diseases: performance on quality indicators, medication use and adherence, and health care utilization. Popul Health Manag. 2011;14(2):99–106. doi:10.1089/pop.2010.002021091367
  • Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6:13. doi:10.1186/1471-2466-6-1316772035
  • Dowse R, Ehlers M. Medicine labels incorporating pictograms: do they influence understanding and adherence? Patient Educ Couns. 2005;58(1):63–70. doi:10.1016/j.pec.2004.06.01215950838
  • Cinar S, Barlas GU, Alpar SE. Stressors and coping strategies in hemodialysis patients. Pak J Med Sci. 2009;25(3):447–452.
  • Minaiyan M, Taheri M, Mirmoghtadaee P, Marasi M. Comparative role of demographic factors and patient’s belief about prescribed medicine on adherence to drug treatment in chronic diseases. J Isfahan Med School. 2011;29:156.
  • Naqvi AA, Hassali MA, Aftab MT, Nadir MN. A qualitative study investigating perceived barriers to medication adherence in chronic illness patients of Karachi, Pakistan. Jpma. 2019;69:216.
  • Duarte-de-Araujo A, Teixeira P, Hespanhol V, Correia-de-Sousa J. COPD: understanding patients’ adherence to inhaled medications. Int J Chron Obstruct Pulmon Dis. 2018;13:2767–2773. doi:10.2147/COPD.S16098230233167
  • Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–354.
  • Plaza V, Fernandez-Rodriguez C, Melero C, et al. Validation of the ‘Test of the Adherence to Inhalers’ (TAI) for asthma and COPD patients. J Aerosol Med Pulm Drug Deliv. 2016;29(2):142–152. doi:10.1089/jamp.2015.121226230150
  • Ayele AA, Tegegn HG. Non adherence to inhalational medications and associated factors among patients with asthma in a referral hospital in Ethiopia, using validated tool TAI. Asthma Res Pract. 2017;3(1):7. doi:10.1186/s40733-017-0035-029046815
  • Aliabadi F, Borimnejad L, Kamali M, Rassafiani M, Nazi S. Perceived Maternal Parenting Self-Efficacy (PMP SE) tool: translation and face validation with Iranian mothers of hospitalized preterm neonates. Iran Rehabil J. 2013;11:7–10.
  • Lawshe CH. A quantitative approach to content validity 1. Pers Psychol. 1975;28(4):563–575. doi:10.1111/peps.1975.28.issue-4
  • LoBiondo-Wood G, Haber J. Nursing Research: Methods and Critical Appraisal for Evidence-based Practice. 8th ed. Mosby- Elsevier; 2014.
  • Rodrigues IB, Adachi JD, Beattie KA, MacDermid JC. Development and validation of a new tool to measure the facilitators, barriers and preferences to exercise in people with osteoporosis. BMC Musculoskelet Disord. 2017;18(1):540. doi:10.1186/s12891-017-1624-z29258503
  • Yaghmaie F. Content validity and its estimation. J Med Educ. 2003;3:1.
  • Naqvi AA, Hassali MA, Rizvi M, et al. Development and validation of a novel General Medication Adherence Scale (GMAS) for chronic illness patients in Pakistan. Front Pharmacol. 2018;9:1124. doi:10.3389/fphar.2018.0112430356775
  • Naqvi AA, Hassali MA, Jahangir A, Nadir MN, Kachela B. Translation and validation of the English version of the general medication adherence scale (GMAS) in patients with chronic illnesses. J Drug Assess. 2019;8(1):36–42. doi:10.1080/21556660.2019.157972930863660
  • Yurdugül H. Minimum sample size for Cronbach’s coefficient alpha: a Monte-Carlo study. Hacettepe Üniversitesi Egitim Fakültesi Dergisi. 2008;35(35):1–9.
  • Fleiss JL. Design and Analysis of Clinical Experiments. Vol. 73 John Wiley & Sons; 2011.
  • de Boer MR, Moll AC, de Vet HC, Terwee CB, Volker-Dieben HJ, van Rens GH. Psychometric properties of vision-related quality of life questionnaires: a systematic review. Ophthalmic Physiol Optics. 2004;24(4):257–273. doi:10.1111/j.1475-1313.2004.00187.x
  • Polit DF, Beck CT, Owen SV. Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Res Nurs Health. 2007;30(4):459–467. doi:10.1002/nur.2019917654487
  • Declaration H. Human experimentation: code of ethics of World Medical Association Br. Br Med J. 1964;2:18.
  • Plaza V, López-Viña A, Cosio BG. Test of adherence to inhalers. Archivos De Bronconeumología. 2017;53(7):360–361. doi:10.1016/j.arbr.2017.03.00527756657
  • Montes de Oca M, Menezes A, Wehrmeister FC, et al. Adherence to inhaled therapies of COPD patients from seven Latin American countries: the LASSYC study. PLoS One. 2017;12(11):e0186777. doi:10.1371/journal.pone.018677729140978